URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Peter Kouides

Concepts (298)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Menorrhagia
21
2001
28
7.220
Why?
von Willebrand Diseases
15
1998
22
5.680
Why?
Hemostasis
8
1998
62
3.440
Why?
Hemophilia A
7
2009
37
2.860
Why?
Hemorrhage
9
2001
181
2.800
Why?
Blood Coagulation Disorders
8
2002
37
1.950
Why?
Menstruation
6
1998
16
1.530
Why?
Coagulants
2
2008
13
1.500
Why?
Antifibrinolytic Agents
5
2008
18
1.410
Why?
Hemostatics
6
2006
23
1.360
Why?
Delivery of Health Care
2
2009
145
1.220
Why?
Humans
72
1988
36400
1.210
Why?
Heparin
2
2005
125
1.140
Why?
Physician's Practice Patterns
2
2009
253
1.130
Why?
Tranexamic Acid
4
2008
7
1.120
Why?
Anticoagulants
2
2005
135
1.090
Why?
Deamino Arginine Vasopressin
5
2006
24
1.090
Why?
Factor X Deficiency
2
2001
2
1.070
Why?
Factor VIII
4
2009
107
1.010
Why?
Blood Coagulation Factors
5
2001
54
1.000
Why?
Uterine Hemorrhage
2
2004
25
0.990
Why?
Female
43
1993
19826
0.970
Why?
Hemophilia B
2
2009
12
0.930
Why?
Biopsy
2
2006
359
0.890
Why?
Myelodysplastic Syndromes
5
1992
133
0.890
Why?
Blood Loss, Surgical
2
2008
45
0.870
Why?
Antibodies, Monoclonal
2
2006
732
0.830
Why?
Blood Platelet Disorders
3
2004
7
0.790
Why?
Thrombosis
1
2012
199
0.720
Why?
Polyps
1
2009
9
0.720
Why?
Factor IX
1
2009
12
0.720
Why?
Perioperative Care
1
2009
24
0.720
Why?
Postoperative Hemorrhage
1
2009
18
0.710
Why?
Purpura, Thrombocytopenic
3
1995
15
0.700
Why?
Colonoscopy
1
2009
41
0.700
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2008
94
0.690
Why?
Venous Thromboembolism
1
2009
28
0.680
Why?
Gastrointestinal Hemorrhage
1
2009
84
0.680
Why?
Factor X
1
2008
30
0.660
Why?
Platelet Function Tests
5
2004
15
0.650
Why?
Pregnancy Complications, Hematologic
4
2001
29
0.640
Why?
von Willebrand Factor
5
2008
68
0.640
Why?
Antineoplastic Combined Chemotherapy Protocols
4
1993
430
0.630
Why?
Adult
27
1988
11345
0.620
Why?
Lymphoma, T-Cell
1
2007
11
0.610
Why?
Registries
1
2008
223
0.610
Why?
Splenic Neoplasms
1
2007
11
0.600
Why?
Crohn Disease
1
2007
88
0.580
Why?
Women
1
2006
18
0.560
Why?
Prostatic Neoplasms
1
2012
556
0.560
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2006
5
0.550
Why?
Liver Neoplasms
1
2007
152
0.550
Why?
Prevalence
4
2005
541
0.550
Why?
Leukemia, Myeloid, Acute
2
1999
179
0.510
Why?
Hysterectomy
1
2004
33
0.500
Why?
Embolization, Therapeutic
1
2004
40
0.490
Why?
Endometrium
1
2004
46
0.490
Why?
Thrombocytopenia
1
2005
76
0.480
Why?
Catheter Ablation
1
2004
76
0.460
Why?
Quality of Life
6
2000
509
0.460
Why?
Middle Aged
20
1993
9877
0.460
Why?
Male
23
1988
19713
0.430
Why?
Child
9
1995
4086
0.420
Why?
Pregnancy
7
1998
1962
0.390
Why?
Treatment Outcome
7
1993
2623
0.390
Why?
Genitalia, Female
1
2000
23
0.380
Why?
Genital Diseases, Female
1
2000
33
0.380
Why?
Bone Marrow Transplantation
6
1993
186
0.380
Why?
Administration, Oral
3
2009
309
0.380
Why?
6-Aminocaproic Acid
2
2009
8
0.370
Why?
Adolescent
10
1993
4752
0.370
Why?
Rare Diseases
2
2008
28
0.370
Why?
Antineoplastic Agents
1
2006
625
0.360
Why?
Young Adult
5
2008
1074
0.340
Why?
Granulocyte Colony-Stimulating Factor
2
1995
46
0.340
Why?
Forecasting
2
2009
178
0.340
Why?
Cytarabine
2
1995
91
0.320
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
1993
56
0.310
Why?
Mass Screening
3
2006
252
0.310
Why?
Blood Coagulation Tests
2
2004
41
0.290
Why?
Sulfhemoglobinemia
1
1996
1
0.290
Why?
Cyanosis
1
1996
4
0.290
Why?
Methylene Blue
1
1996
12
0.280
Why?
Flutamide
1
1996
27
0.280
Why?
Multiple Endocrine Neoplasia Type 1
1
1996
5
0.280
Why?
Antineoplastic Agents, Hormonal
1
1996
46
0.270
Why?
Blast Crisis
1
1995
21
0.270
Why?
Clinical Laboratory Techniques
2
2002
39
0.270
Why?
Red-Cell Aplasia, Pure
1
1995
8
0.270
Why?
Cell Transformation, Neoplastic
2
1995
136
0.260
Why?
Questionnaires
4
2000
998
0.260
Why?
Leukemia, Lymphoid
1
1995
63
0.260
Why?
Leukemia, Myelomonocytic, Chronic
1
1995
20
0.260
Why?
Pericarditis
1
1995
12
0.260
Why?
Aged
11
1993
7272
0.250
Why?
Chromosomes, Human, Pair 18
1
1994
15
0.250
Why?
Chromosomes, Human, Pair 14
1
1994
17
0.250
Why?
Chromosomes, Human, Pair 19
1
1994
14
0.250
Why?
Chromosomes, Human, Pair 1
1
1994
25
0.250
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1995
77
0.250
Why?
Burkitt Lymphoma
1
1994
47
0.250
Why?
Translocation, Genetic
1
1994
64
0.240
Why?
Leukemia
1
1995
154
0.240
Why?
Postpartum Hemorrhage
3
2006
8
0.240
Why?
Respiratory Distress Syndrome, Adult
1
1995
78
0.240
Why?
Contraceptives, Oral, Combined
2
2008
5
0.240
Why?
Immunosuppressive Agents
1
1995
196
0.230
Why?
Practice Guidelines as Topic
3
2009
304
0.220
Why?
Sex Characteristics
2
2001
142
0.220
Why?
Retrospective Studies
4
1995
2260
0.220
Why?
Blood Coagulation Factor Inhibitors
1
2012
1
0.210
Why?
Chicago
1
2012
6
0.210
Why?
Hematology
2
2002
13
0.210
Why?
Charcoal
1
2012
17
0.210
Why?
Antidotes
1
2012
17
0.210
Why?
Congresses as Topic
1
2012
34
0.210
Why?
Factor Xa
1
2012
40
0.210
Why?
Blood Coagulation Disorders, Inherited
1
2011
1
0.200
Why?
Prostate-Specific Antigen
1
2012
114
0.200
Why?
Hemorrhagic Disorders
1
2011
5
0.200
Why?
Epistaxis
1
2010
4
0.190
Why?
Hormone Replacement Therapy
1
2011
15
0.190
Why?
Thrombin
1
2012
157
0.190
Why?
Contusions
1
2010
20
0.190
Why?
Immune Tolerance
1
2011
144
0.190
Why?
Remission Induction
2
1995
163
0.190
Why?
Medical History Taking
1
2010
67
0.190
Why?
Vitamin K
1
2009
8
0.180
Why?
Upper Gastrointestinal Tract
1
2009
1
0.180
Why?
Helicobacter Infections
1
2009
8
0.180
Why?
Premedication
1
2009
21
0.180
Why?
Labor, Obstetric
2
1998
33
0.180
Why?
Platelet Transfusion
1
2010
86
0.180
Why?
Cyclooxygenase 2 Inhibitors
1
2009
64
0.170
Why?
Biomedical Research
1
2011
140
0.170
Why?
Iran
1
2008
4
0.170
Why?
Administration, Intranasal
1
2009
61
0.170
Why?
Italy
1
2008
21
0.170
Why?
Deferoxamine
1
1988
17
0.170
Why?
Headache
1
2009
49
0.170
Why?
Plasma
1
2008
33
0.170
Why?
Cross-Over Studies
1
2009
126
0.170
Why?
Prospective Studies
3
1993
1677
0.170
Why?
Disease Management
3
2002
26
0.170
Why?
Homozygote
1
2008
90
0.170
Why?
Great Britain
1
2008
98
0.160
Why?
Heterozygote
1
2008
122
0.160
Why?
Risk Factors
2
1998
2318
0.160
Why?
Mutation, Missense
1
2008
87
0.160
Why?
Placenta Diseases
1
2007
18
0.160
Why?
Evidence-Based Medicine
1
2009
199
0.150
Why?
Hematologic Tests
1
2007
9
0.150
Why?
Diagnosis, Differential
3
1997
878
0.150
Why?
Follow-Up Studies
3
1995
1857
0.150
Why?
Mastocytosis, Systemic
1
2007
4
0.150
Why?
Pneumonia, Pneumocystis
1
1988
119
0.150
Why?
Arteries
1
2007
80
0.150
Why?
Genotype
1
2008
487
0.150
Why?
Recombinant Proteins
1
2009
768
0.140
Why?
Infant
2
2008
2249
0.140
Why?
Randomized Controlled Trials as Topic
2
2004
409
0.140
Why?
Menstruation Disturbances
1
2006
8
0.140
Why?
Placenta
1
2007
145
0.140
Why?
Pain
1
2009
382
0.140
Why?
Lymphoma
2
1993
163
0.140
Why?
Injections, Intravenous
1
2006
131
0.140
Why?
Severity of Illness Index
2
1993
919
0.130
Why?
Antibodies, Monoclonal, Murine-Derived
1
2006
132
0.130
Why?
Lymphoma, Follicular
1
2006
61
0.130
Why?
Lymphoma, Non-Hodgkin
2
1995
113
0.130
Why?
Dexamethasone
1
2006
183
0.130
Why?
Anti-Inflammatory Agents
1
2006
116
0.130
Why?
Postoperative Period
1
2004
85
0.120
Why?
Heavy Chain Disease
1
2003
2
0.120
Why?
Immunoglobulin lambda-Chains
1
2003
19
0.120
Why?
Amyloidosis
1
2003
27
0.120
Why?
Thalassemia
2
1988
23
0.120
Why?
Immunoglobulin Heavy Chains
1
2003
48
0.120
Why?
Infant, Newborn
1
2008
1831
0.110
Why?
Skin
1
2006
381
0.110
Why?
Hodgkin Disease
2
1993
153
0.110
Why?
Child, Preschool
4
1997
2612
0.110
Why?
Premenopause
1
2002
13
0.110
Why?
Postmenopause
1
2002
43
0.100
Why?
Physical Examination
1
2002
88
0.100
Why?
Obstetric Labor Complications
1
2001
20
0.100
Why?
Home Infusion Therapy
1
2001
1
0.100
Why?
Transplantation, Homologous
2
1995
260
0.090
Why?
Prognosis
3
1993
1080
0.090
Why?
Meninges
1
1999
21
0.090
Why?
Fatal Outcome
2
1996
109
0.090
Why?
Flow Cytometry
2
1995
597
0.090
Why?
Multiple Myeloma
1
1999
76
0.090
Why?
Platelet Aggregation
2
2007
67
0.090
Why?
Corynebacterium Infections
1
1998
8
0.080
Why?
Meningeal Neoplasms
1
1999
51
0.080
Why?
United States
3
2011
2630
0.080
Why?
Infectious Mononucleosis
1
1998
10
0.080
Why?
Parvoviridae Infections
1
1998
11
0.080
Why?
Algorithms
1
2002
537
0.080
Why?
Risk Assessment
3
2002
878
0.080
Why?
Cohort Studies
2
2011
969
0.080
Why?
Anemia, Sideroblastic
1
1997
9
0.080
Why?
Copper
1
1997
59
0.070
Why?
Methemoglobinemia
1
1996
1
0.070
Why?
Anemia
1
1997
77
0.070
Why?
Brain Neoplasms
1
1999
282
0.070
Why?
Aged, 80 and over
2
1995
2513
0.070
Why?
Treatment Failure
1
1996
130
0.070
Why?
Sex Factors
1
1998
584
0.070
Why?
Daunorubicin
1
1995
24
0.070
Why?
Hypersensitivity, Delayed
1
1996
49
0.070
Why?
Case-Control Studies
2
2004
618
0.070
Why?
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
1
1995
11
0.070
Why?
Recurrence
4
1993
697
0.070
Why?
Antineoplastic Agents, Alkylating
1
1996
41
0.070
Why?
Drug Hypersensitivity
1
1996
36
0.070
Why?
Clinical Trials as Topic
2
2008
675
0.070
Why?
Cyclophosphamide
1
1996
173
0.070
Why?
Immunophenotyping
1
1995
124
0.060
Why?
Hepatitis B
1
1995
19
0.060
Why?
Neoplasm Metastasis
1
1996
229
0.060
Why?
Hydroxyquinolines
1
1993
9
0.060
Why?
Acute Disease
2
1995
580
0.060
Why?
Bone Marrow
1
1994
290
0.060
Why?
Adjuvants, Immunologic
1
1993
120
0.050
Why?
Apoptosis
1
1999
855
0.050
Why?
Stem Cell Transplantation
1
1993
113
0.050
Why?
Drug Monitoring
1
2012
36
0.050
Why?
Drug Interactions
1
2012
186
0.050
Why?
Contraceptive Agents, Female
1
2011
3
0.050
Why?
Drug Combinations
1
2011
151
0.050
Why?
Hematologic Diseases
1
2011
37
0.050
Why?
Hematopoiesis
1
1992
123
0.050
Why?
Menstrual Cycle
1
2011
14
0.050
Why?
Transplantation, Autologous
3
1993
144
0.050
Why?
Protein C
1
2011
47
0.050
Why?
Population Surveillance
1
2011
137
0.050
Why?
Electrocardiography
1
1995
782
0.040
Why?
Longitudinal Studies
1
2011
390
0.040
Why?
Decision Trees
1
2009
28
0.040
Why?
Joint Diseases
1
2009
30
0.040
Why?
Liver Diseases
1
2009
80
0.040
Why?
Intrauterine Devices, Medicated
1
2008
1
0.040
Why?
Levonorgestrel
1
2008
3
0.040
Why?
Danazol
1
2008
4
0.040
Why?
Phenotype
1
2011
762
0.040
Why?
Kidney Failure, Chronic
1
2009
119
0.040
Why?
Progestins
1
2008
15
0.040
Why?
Hypertension, Malignant
1
2007
6
0.040
Why?
Purpura, Thrombotic Thrombocytopenic
1
2007
11
0.040
Why?
Hemostasis, Surgical
1
2008
11
0.040
Why?
Plasmapheresis
1
2007
25
0.040
Why?
ADAM Proteins
1
2007
14
0.040
Why?
Ticlopidine
1
2007
6
0.040
Why?
Plasma Exchange
1
2007
18
0.040
Why?
Gonadotropin-Releasing Hormone
1
2008
44
0.040
Why?
Pre-Eclampsia
1
2007
27
0.040
Why?
Comorbidity
1
2009
374
0.040
Why?
Platelet Aggregation Inhibitors
1
2007
59
0.040
Why?
Aspirin
1
2007
56
0.040
Why?
Drug Resistance
1
2007
101
0.040
Why?
Prednisone
1
2007
177
0.040
Why?
Drug Therapy, Combination
1
2007
390
0.040
Why?
Cardiovascular Diseases
1
2009
276
0.030
Why?
Coagulation Protein Disorders
1
2004
2
0.030
Why?
Fluorescent Antibody Technique, Direct
1
2003
8
0.030
Why?
Kidney Glomerulus
1
2003
26
0.030
Why?
Basement Membrane
1
2003
31
0.030
Why?
Nephrotic Syndrome
1
2003
27
0.030
Why?
Amyloid
1
2003
20
0.030
Why?
Reference Values
1
2004
441
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2003
117
0.030
Why?
Neoplasms
1
2009
723
0.030
Why?
Combined Modality Therapy
2
1993
486
0.030
Why?
Sensitivity and Specificity
1
2004
905
0.020
Why?
Granulocytes
1
1999
84
0.020
Why?
Bone Marrow Examination
1
1998
23
0.020
Why?
Blood Cell Count
1
1998
42
0.020
Why?
Radiotherapy
1
1999
198
0.020
Why?
Neoplasm, Residual
1
1997
20
0.020
Why?
Cerebral Cortex
1
1999
250
0.020
Why?
Bone Marrow Cells
1
1998
223
0.020
Why?
Skin Tests
1
1996
27
0.020
Why?
Immunoglobulin E
1
1996
48
0.020
Why?
Hepatitis B e Antigens
1
1995
3
0.020
Why?
Hepatitis B Surface Antigens
1
1995
7
0.020
Why?
Multivariate Analysis
1
1997
531
0.020
Why?
Antibodies
1
1996
216
0.020
Why?
Disease-Free Survival
1
1995
202
0.020
Why?
Actuarial Analysis
1
1993
21
0.020
Why?
Leukemia, Myeloid
1
1995
122
0.010
Why?
Survival Rate
1
1995
619
0.010
Why?
Proportional Hazards Models
1
1993
453
0.010
Why?
Predictive Value of Tests
1
1993
601
0.010
Why?
Age Factors
1
1995
1121
0.010
Why?
Survival Analysis
1
1993
598
0.010
Why?
Time Factors
1
1996
3201
0.010
Why?

Visualizations


Kouides's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department